Metabolic syndrome, aging and involvement of oxidative stress
- PMID: 25821639
- PMCID: PMC4365955
- DOI: 10.14336/AD.2014.0305
Metabolic syndrome, aging and involvement of oxidative stress
Abstract
The prevalence of the metabolic syndrome, a cluster of cardiovascular risk factors associated with obesity and insulin resistance, is dramatically increasing in Western and developing countries. This disorder consists of a cluster of metabolic conditions, such as hypertriglyceridemia, hyper-low-density lipoproteins, hypo-high-density lipoproteins, insulin resistance, abnormal glucose tolerance and hypertension, that-in combination with genetic susceptibility and abdominal obesity-are risk factors for type 2 diabetes, vascular inflammation, atherosclerosis, and renal, liver and heart diseases. One of the defects in metabolic syndrome and its associated diseases is excess of reactive oxygen species. Reactive oxygen species generated by mitochondria, or from other sites within or outside the cell, cause damage to mitochondrial components and initiate degradative processes. Such toxic reactions contribute significantly to the aging process. In this article we review current understandings of oxidative stress in metabolic syndrome related disease and its possible contribution to accelerated senescence.
Keywords: accelerated senescence; aging; metabolic syndrome; oxidative stress.
Figures
Similar articles
-
Metabolic syndrome and mitochondrial function: molecular replacement and antioxidant supplements to prevent membrane peroxidation and restore mitochondrial function.J Cell Biochem. 2007 Apr 15;100(6):1352-69. doi: 10.1002/jcb.21247. J Cell Biochem. 2007. PMID: 17243117 Review.
-
Mitochondrial free radical generation, oxidative stress, and aging.Free Radic Biol Med. 2000 Aug;29(3-4):222-30. doi: 10.1016/s0891-5849(00)00317-8. Free Radic Biol Med. 2000. PMID: 11035250 Review.
-
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome.Am J Cardiol. 1999 May 13;83(9B):25F-29F. doi: 10.1016/s0002-9149(99)00211-8. Am J Cardiol. 1999. PMID: 10357572 Review.
-
Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection.Molecules. 2018 Jan 17;23(1):191. doi: 10.3390/molecules23010191. Molecules. 2018. PMID: 29342113 Free PMC article. Review.
-
Insulin resistance in obesity as the underlying cause for the metabolic syndrome.Mt Sinai J Med. 2010 Sep-Oct;77(5):511-23. doi: 10.1002/msj.20212. Mt Sinai J Med. 2010. PMID: 20960553 Review.
Cited by
-
A weighty problem: metabolic perturbations and the obesity-cancer link.Horm Mol Biol Clin Investig. 2015 Aug;23(2):47-57. doi: 10.1515/hmbci-2015-0022. Horm Mol Biol Clin Investig. 2015. PMID: 26167982 Free PMC article. Review.
-
Potential Drug-Drug Interactions and Related Factors among Geriatric Outpatients of a Tertiary Care Hospital.Geriatrics (Basel). 2023 Nov 14;8(6):111. doi: 10.3390/geriatrics8060111. Geriatrics (Basel). 2023. PMID: 37987471 Free PMC article.
-
Endotheliopathy in the metabolic syndrome: Mechanisms and clinical implications.Pharmacol Ther. 2023 Apr;244:108372. doi: 10.1016/j.pharmthera.2023.108372. Epub 2023 Mar 7. Pharmacol Ther. 2023. PMID: 36894027 Free PMC article. Review.
-
High calories but not fat content of lard-based diet contribute to impaired mitochondrial oxidative phosphorylation in C57BL/6J mice heart.PLoS One. 2019 Jul 2;14(7):e0217045. doi: 10.1371/journal.pone.0217045. eCollection 2019. PLoS One. 2019. PMID: 31265457 Free PMC article.
-
A Novel Sesquiterpene Lactone Xanthatin-13-(pyrrolidine-2-carboxylic acid) Isolated from Burdock Leaf Up-Regulates Cells' Oxidative Stress Defense Pathway.Antioxidants (Basel). 2021 Oct 14;10(10):1617. doi: 10.3390/antiox10101617. Antioxidants (Basel). 2021. PMID: 34679753 Free PMC article.
References
-
- Humphreys MH (2011). The brain splits obesity and hypertension. Nat Med, 17:782–3. - PubMed
-
- Kahn SE,Hull RL,Utzschneider KM (2006). Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature, 444: 840–6. - PubMed
-
- Giovannucci E,Michaud D (2007). The role of obesity and related metabolic disturbances in cancers of the colon, prostate, and pancreas. Gastroenterology, 132:2208–25. - PubMed
-
- Parekh S,Anania FA (2007). Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology, 132:2191–207. - PubMed
-
- Bamba V,Rader DJ (2007). Obesity and atherogenic dyslipidemia. Gastroenterology, 132:2181–90. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources